机构:[1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangdong 510315, Guangzhou, China[2]Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 511436, China
the National Natural Science Foundation of China (No. 81572247).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|4 区医学
小类|4 区肿瘤学4 区病理学
最新[2025]版:
大类|4 区医学
小类|4 区肿瘤学4 区病理学
第一作者:
第一作者机构:[1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangdong 510315, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangdong 510315, Guangzhou, China[*1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangdong 510315, Guangzhou, China
推荐引用方式(GB/T 7714):
Wang Yubing,Liu Zhen,Luo Rongcheng,et al.Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma.[J].International journal of clinical and experimental pathology.2018,11(2):802-807.
APA:
Wang Yubing,Liu Zhen,Luo Rongcheng&Xie Yingying.(2018).Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma..International journal of clinical and experimental pathology,11,(2)
MLA:
Wang Yubing,et al."Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma.".International journal of clinical and experimental pathology 11..2(2018):802-807